101 – 120 of 212
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Varningsbrev i immaterialrätten
(
- Prof. qual. >4 yrs
-
Mark
Comparison of the Notions of Relevant Market between EC and the US: What Can China Learn from Both Sides?
(
- Master (One yr)
-
Mark
A study of legal protection of Geographical Indications in the European Community and in Vietnam
(
- Master (One yr)
-
Mark
"Private Enforcement of Competition Law from a Corporate Social Responsibility Perspective; Too much of a good thing?"
(
- Master (One yr)
-
Mark
European Private Antitrust Litigation: passing-on defense and indirect purchaser standing - finding a consumer-orientated option
(
- Master (One yr)
-
Mark
The Interface between Intellectual Property Rights and Antitrust law: An Overview of the Microsoft Proceedings in the US and EU.
(
- Master (One yr)
-
Mark
Unpatentable Exceptions to the EPC. The rationale and understanding of Article 53(b) - A historical analysis.
(
- Master (One yr)
-
Mark
Cross- border Competition Law beyond the EU
(
- Master (One yr)
-
Mark
How Collective Marks Can Help Protect the Products of Guatemalan Artisans' Small Businesses in the Local and International Market?
(
- Master (One yr)
-
Mark
Den Andra Medicinska Indikationen
(
- Prof. qual. >4 yrs
-
Mark
Equality and Development
(
- Prof. qual. >4 yrs
- 2006
-
Mark
Patent på mänskliga stamceller - rättsliga och moraliska aspekter
(
- Prof. qual. >4 yrs
-
Mark
Klassificering av läkemedel - en studie av det nationella utrymmet vid harmonisering
(
- Prof. qual. >4 yrs
-
Mark
Läkemedelsindustrin och marknadsuppdelning inom EU - Immaterialrättsliga hinder, konkurrensrättsliga möjligheter? The pharmaceutical industry and market partitioning within the EU - A study of IP- and competition law related aspects.
(
- Prof. qual. >4 yrs
-
Mark
Konkurrenslagens undantag för samarbete inom skogsbruksföreningar
(
- Prof. qual. >4 yrs
-
Mark
The Swedish retail monopoly on pharmaceuticals Is it compatible with EC-Law?
(
- Prof. qual. >4 yrs
-
Mark
Issues Around Bioprospecting, Traditional Knowledge and Access and Benefit Sharing in international and national legislation
(
- Prof. qual. >4 yrs
-
Mark
Abuse of a Dominant Position by Pharmaceutical Undertakings in EC Law
(
- Master (One yr)
-
Mark
Unilateral Effects Analysis in EC Merger Control
(
- Master (One yr)
-
Mark
Information Exchange between Undertakings
(
- Master (One yr)